Redmile Group’s Halozyme HALO Stock Holding History

Redmile Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-64,167	Closed	-$815K	–	53
2014 Q1	$815K	Buy	+64,167	New	+$952K	0.1%	48

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Redmile Group's HALO Position: Q2 2014 in Review

Redmile Group sold out of Halozyme (HALO) in Q2 2014, closing a stake of 64,167 shares — an estimated $815K sold.

Redmile Group first reported a position in HALO in Q1 2014 and held it in 1 quarter. The position peaked at $815K in Q1 2014. 128 funds tracked by Wall St. Rank hold HALO as of Q2 2014.

Redmile Group reported no remaining Halozyme position as of Q2 2014 after selling out during the quarter.
Redmile Group sold 64,167 Halozyme shares in Q2 2014, an estimated $815K.
Redmile Group first reported a position in Halozyme in Q1 2014 and held it in 1 quarter.
Redmile Group's Halozyme position peaked at $815K in Q1 2014.
128 funds tracked by Wall St. Rank held Halozyme as of Q2 2014.

Based on Redmile Group's 13F filing for Q2 2014, filed 15 Aug 2014.